000 | nab a22 7a 4500 | ||
---|---|---|---|
999 |
_c17004 _d17004 |
||
003 | PC17004 | ||
005 | 20221006140008.0 | ||
008 | 221006b xxu||||| |||| 00| 0 eng d | ||
040 | _cH12O | ||
041 | _aspa, eng | ||
100 |
_92042 _aMateo Bernardo, Isabel _eReumatología |
||
100 |
_9891 _aVanaclocha Sebastián, Francisco _eDermatología Médico Quirúrgica y Venereología |
||
245 | 0 | 0 |
_aManifestaciones extraarticulares en pacientes con espondiloartritis. Características basales de la cohorte de pacientes con espondiloartritis del estudio AQUILES. _h[artículo] |
260 |
_bReumatología clínica, _c2015 |
||
300 | _a11(2):83-9. | ||
500 | _aFormato Vancouver: Zarco P, González CM, Rodríguez de la Serna A, Peiró E, Mateo I, Linares L et al. Manifestaciones extraarticulares en pacientes con espondiloartritis. Características basales de la cohorte de pacientes con espondiloartritis del estudio AQUILES. Reumatol Clin. 2015 Mar-Apr;11(2):83-9. | ||
501 | _a PMID: 25441489 | ||
504 | _aContiene 22 referencias | ||
520 | _aObjectives: To describe the prevalence of extra-articular disease (uveitis, psoriasis and inflammatory bowel disease [IBD]), in a cohort of patients with spondyloarthritis (SpA). Patients and methods: AQUILES is an observational, prospective and multicentric study of three cohorts of patients with one of the following immune-mediated inflammatory diseases (IMID): SpA, psoriasis, or IBD. In the present cohort, patients ≥18 years of age with SpA were enrolled from Rheumatology clinics. The main objective was to assess the coexistence of these diseases and of uveitis, based on the patients' clinical history up to the study entry. Results: A total of 601 patients with SpA (men: 63.1%; women: 36.9%) were enrolled. The specific diagnoses were: ankylosing spondylitis (55.1%), psoriatic arthritis (25.1%), undifferentiated spondyloarthritis (16.1%), enteropathic arthritis (2.5%), and others (1.3%). In 43.6% (95% CI: 39.7-47.6) of the patients, at least one of the three abovementioned diseases was encountered, predominantly psoriasis (prevalence 27.8%, 95% CI: 24.4-31.5), uveitis (13.6%, CI 95%: 11.1-16.6) and IBD (5.1%, 95% CI: 3.7-7.2). In patients with ankylosing spondylitis the proportion of other disease was 25.3% (IBD: 3.9%, psoriasis: 5.4%, uveitis: 19.0%) whilst it was 94.7% in psoriatic arthritis, due to the presence of psoriasis (94.0%). The coexistence of these diseases was associated with age, female gender and the presence of other extra-articular manifestations associated with SpA. Conclusions: Extra-articular disease in patients with SpA is common and, in this study, it was associated to age, female gender and the presence of other SpA-related extra-articular manifestations. | ||
710 |
_9123 _aServicio de Reumatología |
||
710 |
_9145 _aServicio de Dermatología Médico-Quirúrgica y Venereología |
||
856 |
_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/1/pc17004.pdf _ySolicitar documento |
||
942 |
_2ddc _cART _n0 |